Sequoia Financial Advisors, LLC Edwards Lifesciences Corp Transaction History

Sequoia Financial Advisors, LLC

$8.93 Billion
Q3 2024

A detailed history of Sequoia Financial Advisors, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Sequoia Financial Advisors, LLC holds 6,902 shares of EW stock, worth $456,636. This represents 0.01% of its overall portfolio holdings.

Number of Shares

6,902

Previous 8,851 22.02%

Holding current value

$456,636

Previous $817,000 44.31%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$59.7 - $93.78 $116,355 - $182,777	-1,949 Reduced 22.02%	6,902 $455,000
Q2 2024 Jul 15, 2024	SELL	$84.3 - $94.31 $227,188 - $254,165	-2,695 Reduced 23.34%	8,851 $817,000
Q1 2024 Apr 30, 2024	SELL	$72.54 - $95.56 $160,458 - $211,378	-2,212 Reduced 16.08%	11,546 $1.1 Million
Q4 2023 Jan 25, 2024	BUY	$61.71 - $77.76 $252,702 - $318,427	4,095 Added 42.38%	13,758 $1.05 Million
Q3 2023 Nov 08, 2023	SELL	$69.28 - $93.38 $256,336 - $345,506	-3,700 Reduced 27.69%	9,663 $669,000
Q2 2023 Aug 08, 2023	SELL	$81.41 - $94.33 $113,974 - $132,062	-1,400 Reduced 9.48%	13,363 $1.26 Million
Q1 2023 Apr 24, 2023	BUY	$74.26 - $84.51 $99,508 - $113,243	1,340 Added 9.98%	14,763 $1.22 Million
Q4 2022 Jan 17, 2023	BUY	$68.3 - $87.44 $358,370 - $458,797	5,247 Added 64.18%	13,423 $0
Q3 2022 Oct 26, 2022	SELL	$82.37 - $107.29 $39,619 - $51,606	-481 Reduced 5.56%	8,176 $676,000
Q2 2022 Jul 22, 2022	SELL	$86.5 - $128.27 $45,326 - $67,213	-524 Reduced 5.71%	8,657 $823,000
Q1 2022 May 13, 2022	BUY	$101.96 - $128.34 $95,944 - $120,767	941 Added 11.42%	9,181 $1.08 Million
Q4 2021 Feb 11, 2022	BUY	$106.37 - $130.68 $876,488 - $1.08 Million	8,240 New	8,240 $1.07 Million
Q3 2021 Oct 26, 2021	SELL	$102.91 - $122.75 $791,789 - $944,438	-7,694 Closed	0 $0
Q2 2021 Jul 27, 2021	BUY	$83.84 - $104.76 $80,234 - $100,255	957 Added 14.21%	7,694 $797,000
Q1 2021 May 14, 2021	BUY	$78.68 - $90.67 $28,088 - $32,369	357 Added 5.6%	6,737 $563,000
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $430 - $547	6 Added 0.09%	6,380 $582,000
Q3 2020 Oct 23, 2020	SELL	$67.19 - $87.44 $6,450 - $8,394	-96 Reduced 1.48%	6,374 $509,000
Q2 2020 Aug 25, 2020	BUY	$57.54 - $76.95 $372,283 - $497,866	6,470 New	6,470 $447,000
Q2 2020 Aug 11, 2020	SELL	$57.54 - $76.95 $126,300 - $168,905	-2,195 Closed	0 $447,000
Q1 2020 May 11, 2020	SELL	$52.41 - $81.0 $838 - $1,296	-16 Reduced 0.72%	2,195 $414,000
Q4 2019 Feb 13, 2020	BUY	$71.7 - $82.09 $10,253 - $11,738	143 Added 6.91%	2,211 $516,000
Q3 2019 Oct 22, 2019	BUY	$61.55 - $75.43 $6,031 - $7,392	98 Added 4.97%	2,068 $455,000
Q2 2019 Jul 31, 2019	BUY	$55.74 - $64.41 $32,217 - $37,228	578 Added 41.52%	1,970 $364,000
Q1 2019 May 13, 2019	BUY	$47.89 - $64.05 $66,662 - $89,157	1,392 New	1,392 $266,000

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

456M

Call Options Held

6.35M

Put Options Held

2.82M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sequoia Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sequoia Financial Advisors, LLC with notifications on news.

Account

Sequoia Financial Advisors, LLC Edwards Lifesciences Corp Transaction History